Zanetta, Chiara http://orcid.org/0000-0001-6372-360X
Rocca, Maria A. http://orcid.org/0000-0003-2358-4320
Meani, Alessandro http://orcid.org/0000-0001-8189-0452
Martinelli, Vittorio http://orcid.org/0000-0002-5987-5739
Ferrè, Laura http://orcid.org/0000-0002-0559-5301
Moiola, Lucia http://orcid.org/0000-0001-6313-4952
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Article History
Received: 16 February 2023
Revised: 29 March 2023
Accepted: 30 March 2023
First Online: 7 April 2023
Change Date: 17 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00415-023-11772-5
Declarations
:
: Dr. Zanetta received compensation for speaking activities, and/or consulting services from Alexion, Biogen, Merck, Novartis, Roche, Sanofi. Prof. M.A. Rocca received consulting fees from Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche; and speaker honoraria from AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. She receives research support from the MS Society of Canada, the Italian Ministry of Health, and Fondazione Italiana Sclerosi Multipla. She is Associate Editor for <i>Multiple Sclerosis and Related Disorders.</i> Dr. Meani has nothing to disclose. Dr. Martinelli received compensation for speaking and/or for consultancy and support for travel expenses and participation in Congresses from Biogen, Merck-Serono, Novartis, Genzyme and Teva Pharmaceutical Industries. Dr. Ferrè has nothing to disclose. Dr. Moiola received compensation for speaking activities, and/or consulting servicesfrom Merck, Biogen, Novartis, Roche, Sanofi, and TEVA. Prof. Filippi is Editor-in-Chief of the <i>Journal of Neurology</i>, Associate Editor of <i>Human Brain Mapping</i>, <i>Neurological Sciences</i>, and <i>Radiology</i>; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Italian Ministry of Health, and Fondazione Italiana Sclerosi Multipla.
: Approval was received from the local institutional ethical standards committees on human experimentation for any experiments using human subjects. Written informed consent was obtained from all subjects prior to study participation according to the Declaration of Helsinki.